Biogen strongly believes that collaboration with healthcare professionals is crucial to discover, develop and deliver innovative therapies that improve the lives of patients. At the same time, we believe that these interactions must be conducted openly and transparently.
As a member of EFPIA (the European Federation of Pharmaceutical Industries and Associations), Biogen is proud to endorse and uphold the EFPIA Disclosure Code. In line with the code, Biogen has been collecting all payments and contributions made to Healthcare Professionals and Organizations since January 2015.
These will be published in June 2016 or in accordance with the requirements of each local association/law.
Biogen International GmbH is committed to working with patient organizations and supporting their efforts to improve the lives of their members and raise awareness of serious medical conditions. We are aligned in enhancing patient advocacy and supporting medical research for the discovery of effective therapies with a focus on neurological, autoimmune and hematologic disorders.
In 2014, Biogen International provided funding to the patient organizations below in support of several important projects.
|Patient organization||Project||Amount of support|
|European Federation of Neurological Associations||Funding to support project platform and Patient Experience Survey||30 000 EUR|
|European MS Platform, EMSP||European MS Platform, EMSP||190 000 EUR|
|European Patients' Forum||Training on Fundraising for EPF European Members||20 000 EUR|
|EURORDIS||Rare Connect||40 000 EUR|
|International MS Federation, MSIF||Building stronger MS organizations in the Middle East and World MS Day 2014||75 000 GBP|